As most of these risk factors are usually removed in the process of donor evaluation and selection, hereditary thrombophilia such as deficiency of PC, PS, AT-III, and lupus anticoagulants are also risk factors for VTE14 in the healthy population. This evidence concerns the gene PC and Rare hereditary thrombophilia.